The statistics about depression clearly idenThe statistics about depression clearly identify it as a major public health problem tify it as a major public health problem (Greenberg (Greenberg et al et al, 1993) . About 6% of the , 1993). About 6% of the population meet the criteria for major depopulation meet the criteria for major depressive disorder or dysthymia at any time, pressive disorder or dysthymia at any time, and 20% of those with major depressive and 20% of those with major depressive disorder will have symptoms that persist disorder will have symptoms that persist beyond 2 years (Keller beyond 2 years (Keller et al et al, 1992) . The , 1992) . The disorder is highly recurrent; 30% of individisorder is highly recurrent; 30% of individuals experience a relapse within 3 months duals experience a relapse within 3 months of recovery and (in the absence of continof recovery and (in the absence of continuation or maintenance treatment) 50% uation or maintenance treatment) 50% experience a further episode within 2 years. experience a further episode within 2 years. The standardised mortality ratios for uniThe standardised mortality ratios for unipolar depression for accidental deaths, for polar depression for accidental deaths, for deaths by natural causes and for suicide deaths by natural causes and for suicide were 1.4, 1.7 and 19.7, respectively (Ustun, were 1.4, 1.7 and 19.7, respectively (Ustun, 1999) . In the National Health Service the 1999). In the National Health Service the cost of treating depression (£887 million) cost of treating depression (£887 million) exceeds the cost of treating both hyperexceeds the cost of treating both hypertension (£439 million) and diabetes (£300 tension (£439 million) and diabetes (£300 million) (Department of Health, 1996) . million) (Department of Health, 1996) . However, the direct health care costs are However, the direct health care costs are dwarfed by the indirect costs (Berndt dwarfed by the indirect costs (Berndt et al et al, , 2000) . Days lost from work owing to de-2000) . Days lost from work owing to depression exceed all other disorders and the pression exceed all other disorders and the economic burden on family members and economic burden on family members and society is considerable (Broadhead society is considerable (Broadhead et al et al, , 1990 ). This may account for 60-85% of 1990). This may account for 60-85% of the total cost of the illness and represents the total cost of the illness and represents a significant proportion of the gross a significant proportion of the gross national product (Kind & Sorensen, 1993; national product (Kind & Sorensen, 1993; World Health Organization, 2001 ). World Health Organization, 2001 .
Although these data have been well Although these data have been well known within psychiatry for many decades, known within psychiatry for many decades, they had only limited impact on the percepthey had only limited impact on the perceptions of depression within general medicine tions of depression within general medicine and by the public at large (Hays and by the public at large (Hays et al et al, , 1995) . This changed with the World Bank 1995). This changed with the World Bank publication on the global burden of disease publication on the global burden of disease (Murray & Lopez, 1996) . In many ways (Murray & Lopez, 1996) . In many ways the World Bank report was a watershed the World Bank report was a watershed for psychiatry. It provided a meaningful for psychiatry. It provided a meaningful way of communicating, to a wider way of communicating, to a wider audience, the true global impact of audience, the true global impact of depression but it also emphasised to psydepression but it also emphasised to psychiatrists the salience of economic evaluachiatrists the salience of economic evaluations of the cost of treatment of mental tions of the cost of treatment of mental disorders. The report employed a single disorders. The report employed a single standard standard construct, named the DALY construct, named the DALY (disability-adjusted life-year), to quantify (disability-adjusted life-year), to quantify objectively the disease burden. It demonobjectively the disease burden. It demonstrated that in individuals aged 15-44 strated that in individuals aged 15-44 years depression accounted for 10% of years depression accounted for 10% of all DALYs. Furthermore, this figure is proall DALYs. Furthermore, this figure is projected to rise to 15% by the year 2020, jected to rise to 15% by the year 2020, making depression second only to ischaemaking depression second only to ischaemic heart disease in terms of worldwide mic heart disease in terms of worldwide disease burden. The report highlighted that disease burden. The report highlighted that investments in improving health are esseninvestments in improving health are essential for economic development, and stated tial for economic development, and stated that we need to know both the cost and that we need to know both the cost and magnitude of gains that can be expected magnitude of gains that can be expected through improved primary, secondary or through improved primary, secondary or tertiary prevention of depression (Sturm tertiary prevention of depression (Sturm & Wells, 1995 ). & Wells, 1995 .
Research practice has reflected this inResearch practice has reflected this increased interest in health economics, and creased interest in health economics, and many randomised controlled trials (RCTs) many randomised controlled trials (RCTs) now include a cost-effectiveness analysis. now include a cost-effectiveness analysis. However, there are problems in using these However, there are problems in using these data alone to estimate the cost of depresdata alone to estimate the cost of depression. First, RCT research protocols limit sion. First, RCT research protocols limit or eliminate the choices that individuals or eliminate the choices that individuals make about treatment to reduce the varmake about treatment to reduce the variance in clinician and patient behaviours iance in clinician and patient behaviours (Scott & Sensky, 2003) . Second, individuals (Scott & Sensky, 2003) . Second, individuals with depression and concurrent physical or with depression and concurrent physical or mental disorders are rarely included in mental disorders are rarely included in RCTs (only 13% of depression studies inRCTs (only 13% of depression studies include these subjects), whereas such comorclude these subjects), whereas such comorbidity is reported in 50-70% of cases of bidity is reported in 50-70% of cases of depression seen in general practice (Katon depression seen in general practice (Katon & Sullivan, 1990; Kessler & Sullivan, 1990; Kessler et al et al, 1996) . , 1996). Third, primary care physicians treat more Third, primary care physicians treat more individuals with depressive symptoms than individuals with depressive symptoms than are formally diagnosed as having major are formally diagnosed as having major depressive disorder (Johnson depressive disorder (Johnson et al et al, 1992) . , 1992). Again, the former are less likely to be inAgain, the former are less likely to be included in treatment studies. Consequently, cluded in treatment studies. Consequently, economic analyses from RCTs of depreseconomic analyses from RCTs of depression tell us about the cost-effectiveness of sion tell us about the cost-effectiveness of which which treatment the individual received treatment the individual received (Lave (Lave et al et al, 1998) . However, in clinical , 1998). However, in clinical practice the underrecognition and underpractice the underrecognition and undertreatment of depression in primary care treatment of depression in primary care (only 30-40% of individuals with major (only 30-40% of individuals with major depressive disorder receive treatment) depressive disorder receive treatment) means that a more critical economic quesmeans that a more critical economic question is the cost that depends on tion is the cost that depends on whether whether the individual gets the individual gets any any treatment or not treatment or not (Wells (Wells et al et al, 1996) . , 1996).
THE LIDO STUDIES THE LIDO STUDIES
The cities who, despite meeting the criteria for either who, despite meeting the criteria for either major depressive disorder or sub-threshold major depressive disorder or sub-threshold depression, remained depression, remained untreated untreated for at least for at least 3 months. The subjects were also assessed 3 months. The subjects were also assessed for the presence or absence of 12 chronic for the presence or absence of 12 chronic physical health problems, for comorbid physical health problems, for comorbid anxiety or drug and alcohol misuse and anxiety or drug and alcohol misuse and on the SF-12 (a measure of subjective on the SF-12 (a measure of subjective health status). health status).
The paper by Chisholm The paper by Chisholm et al et al makes makes fascinating reading. The first finding to fascinating reading. The first finding to note is the proportion of cases in the differnote is the proportion of cases in the different subgroups: although the number of ent subgroups: although the number of major depressive disorder ( major depressive disorder (n n¼1193) and 1193) and sub-threshold cases ( sub-threshold cases (n n¼1166) was very 1166) was very similar, the rates of comorbid depression similar, the rates of comorbid depression (comorbid major depressive disorder, 21-(comorbid major depressive disorder, 21-43%; comorbid sub-threshold depression, 43%; comorbid sub-threshold depression, 21-35%) exceeded those of pure major de-21-35%) exceeded those of pure major depressive disorder (11-25%) or pure subpressive disorder (11-25%) or pure subthreshold depression (12-28%) at all sites. threshold depression (12-28%) at all sites. Second, the findings on cost were contrary Second, the findings on cost were contrary to what we might reasonably predict. There to what we might reasonably predict. There were marked discrepancies in resource utiliwere marked discrepancies in resource utilisation between sites but no differences in sation between sites but no differences in how providers approached the treatment how providers approached the treatment of sub-threshold depression or major of sub-threshold depression or major depressive disorder in any culture, and depressive disorder in any culture, and depression in the presence of a comorbid depression in the presence of a comorbid medical disorder led to higher resource medical disorder led to higher resource use at only 50% of the sites. use at only 50% of the sites.
The most intriguing finding was an The most intriguing finding was an association between the individual's perassociation between the individual's perceived health status (on the SF-12) and ceived health status (on the SF-12) and the amount of health care they sought. At the amount of health care they sought. At
G LOB AL BUR D E N OF D E P R E S S ION G LOB A L BU R D E N OF D E P R E S S ION
all six sites, it was self-reported health staall six sites, it was self-reported health status rather than comorbidity that had a tus rather than comorbidity that had a cost-raising influence on health care use. cost-raising influence on health care use. This supports previous research that subjecThis supports previous research that subjective rather than objective levels of distress tive rather than objective levels of distress may may dictate service use (Manning & dictate service use (Manning & Wells, 1992; von Korff Wells, 1992; von Korff et al et al, 1992) . , 1992). Chisholm Chisholm et al et al do not report on any redo not report on any relationship lationship between severity of depression between severity of depression and selfand self-reported health status, so we canreported health status, so we cannot determine whether individuals who not determine whether individuals who are more depressed are less satisfied with are more depressed are less satisfied with their physical health, whether a subjective their physical health, whether a subjective sense of poorer physical health increases sense of poorer physical health increases the severity of depression or if the rethe severity of depression or if the relationship is bidirectional. We can hylationship is bidirectional. We can hypothesise that any association between pothesise that any association between depression and subjective and objective depression and subjective and objective physical status may be causal, non-causal physical status may be causal, non-causal or independent, which may result in addior independent, which may result in additive, multiplied or exponential increases in tive, multiplied or exponential increases in the cost of care (Sturm & Wells, 1995 ; the cost of care (Sturm & Wells, 1995; Wells Wells et al et al, 1996) . , 1996). Obviously the LIDO studies cannot Obviously the LIDO studies cannot provide answers to all our questions and provide answers to all our questions and we can only speculate about how the patwe can only speculate about how the pattern and variation in resource utilisation retern and variation in resource utilisation reflects the characteristics of the different flects the characteristics of the different health care delivery systems. For example, health care delivery systems. For example, it can be hypothesised that the small differit can be hypothesised that the small differences between subgroup treatment costs ences between subgroup treatment costs (as in St Petersberg) are indicative of less-(as in St Petersberg) are indicative of lessindividualised approaches to treatment in individualised approaches to treatment in that culture. In contrast, in Seattle there that culture. In contrast, in Seattle there is an incremental increase in treatment is an incremental increase in treatment costs in the three comorbid subgroups, costs in the three comorbid subgroups, which may suggest a highly differentiated which may suggest a highly differentiated approach to treatment. approach to treatment.
IMPLICATIONS IMPLICATIONS
There is a paucity of information on the There is a paucity of information on the economic consequences of depression in economic consequences of depression in an international context (Ormel an international context (Ormel et al et al, , 1994) . Therefore, the LIDO studies on 1994). Therefore, the LIDO studies on cross-cultural similarities and differences cross-cultural similarities and differences in health care utilisation and the lost in health care utilisation and the lost human capital associated with depression human capital associated with depression deserve attention. The economic burden of deserve attention. The economic burden of untreated depression is graphically illuuntreated depression is graphically illustrated by the fact that at four of the six strated by the fact that at four of the six research sites the total health care conresearch sites the total health care consumption per subject approached, or was sumption per subject approached, or was greater than, the average per capita health greater than, the average per capita health care expenditure in that country. Chisholm care expenditure in that country. Chisholm et al et al describe the cost of depression but candescribe the cost of depression but cannot relate this to clinical outcome. Consenot relate this to clinical outcome. Consequently, the LIDO study does not identify quently, the LIDO study does not identify which, if any, of the services represent value which, if any, of the services represent value for money (Sturm & Wells, 1995) . Previous for money (Sturm & Wells, 1995) . Previous research in the USA suggests that successful research in the USA suggests that successful treatment of an acute episode of depression treatment of an acute episode of depression is more expensive (about 30-50% higher is more expensive (about 30-50% higher cost) but more cost-effective than inadecost) but more cost-effective than inadequate treatment, but these findings only quate treatment, but these findings only apply to cases meeting the criteria for major apply to cases meeting the criteria for major depressive disorder (McCoombs depressive disorder (McCoombs et al et al, , 1990; Simon 1990; Simon et al et al, 1995) . There is no ro-, 1995). There is no robust evidence regarding the clinical effecbust evidence regarding the clinical effectiveness or cost-effectiveness of treatments tiveness or cost-effectiveness of treatments for sub-threshold depression (Agency for for sub-threshold depression (Agency for Health Care Policy and Research, 1993; Health Care Policy and Research, 1993; Lave Lave et al et al, 1998 ). This may not be a major , 1998). This may not be a major issue for health economists, because reissue for health economists, because research demonstrates that more severe episearch demonstrates that more severe episodes of major depressive disorder are sodes of major depressive disorder are more likely to be treated. It is argued that more likely to be treated. It is argued that strengthening the capacity of any primary strengthening the capacity of any primary care system to identify and treat these cases care system to identify and treat these cases will theoretically have an impact on the will theoretically have an impact on the overall burden of disease (von Korff overall burden of disease (von Korff et al et al, , 1998) . However, there are clinical draw-1998). However, there are clinical drawbacks to applying this strategy in isolation. backs to applying this strategy in isolation. For example, 80% of individuals with subFor example, 80% of individuals with subthreshold symptoms will go on to experithreshold symptoms will go on to experience an episode of major depressive disence an episode of major depressive disorder (Judd order (Judd et al et al, 1998) , so we need , 1998), so we need information about any longer-term benefits information about any longer-term benefits of treating these cases. Most importantly, of treating these cases. Most importantly, there is a need to produce a shift in treatthere is a need to produce a shift in treatment strategies for depression. The clinical ment strategies for depression. The clinical and health-economic focus on the manageand health-economic focus on the management of discrete episodes of major depresment of discrete episodes of major depressive disorder is outdated and there is a sive disorder is outdated and there is a need to treat depression as a chronic disneed to treat depression as a chronic disorder characterised by recurrent episodes order characterised by recurrent episodes over a lifetime (Scott over a lifetime (Scott et al et al, 2002) . If depres-, 2002) . If depression is viewed in this way, the most costsion is viewed in this way, the most costeffective treatment will be the one that effective treatment will be the one that prevents relapse. Given the increasing prevents relapse. Given the increasing global burden of depression, we suggest global burden of depression, we suggest that a crucial next step in research is to that a crucial next step in research is to identify cross-national similarities and identify cross-national similarities and differences in the costs and long-term differences in the costs and long-term prognosis of depression. prognosis of depression. 
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